-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The role of B cells in systemic lupus erythematosus (SLE) is clear, but its role in chronic cutaneous lupus erythematosus (CCLE) is currently unclear
.
Therefore, this study compares the B cell and autoantibody profiles of patients with SLE , CCLE and both .Compare the B cell and autoantibody profiles of patients with SLE , CCLE and both
Flow cytometry was used to compare the B cell subpopulations of four groups of healthy controls, CCLE without SLE (CCLE+/SLE-), SLE with CCLE (SLE+/CCLE+), or SLE without CCLE (SLE+/CCLE-)
.
Serum was used to measure self-reactivity 9G4+, anti-double-stranded DNA, anti-chromosome and anti-RNA antibodies by ELISA, and anti-RNA binding protein (RBP) was measured by luciferase immunoprecipitation
CCLE+/SLE- patients have the same B cell subgroup abnormalities as SLE patients, although the degree is less than that of SLE patients: unconverted memory B cells are reduced and effector B cells are increased
.
Similarly, CCLE+/SLE- patients and SLE patients have higher levels of 9G4+ IgG autoantibodies , although CCLE+/SLE- patients have lower levels of anti-nucleic acid antibodies and anti-RBP antibodies
Decrease of unconverted memory B cells and increase of effector B cells.
CCLE+/SLE- patients and SLE patients have higher levels of 9G4+ IgG autoantibodies, similar to SLE- like B cell composition (higher serum antibody levels and more prone to disseminated skin damage) And normal B cell composition
in conclusion:
in conclusion:The B cell balance of CCLE is broken, and the tolerance of some B cells is broken
.
CCLE is immunologically heterogeneous, including a part of B cell composition like SLE , and its clinical manifestations are also related to increased levels of autoantibodies and more extensive skin damage .
CCLE is immunologically heterogeneous, including a part of B cell composition like SLE , and its clinical manifestations are also related to increased levels of autoantibodies and more extensive skin damage
Source:
Jenks SA, Wei C, Bugrovsky R, Hill A, Wang X, Rossi FM, Cashman K, Woodruff MC, Aspey LD, Lim SS, Bao G, Drenkard C, Sanz I.
B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.
Ann Rheum Dis.
2021 Sep;80(9):1190-1200.
Jenks SA, Wei C, Bugrovsky R, Hill A, Wang X, Rossi FM, Cashman K, Woodruff MC, Aspey LD, Lim SS, Bao G, Drenkard C, Sanz I.
B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.
Ann Rheum Dis.
2021 Sep;80(9):1190-1200.
doi: 10.
1136/annrheumdis-2021-220349.
Epub 2021 Jun 3.
PMID: 34083207.
Leave a message here